An unusual reaction to telbivudine:rhabdomyolysis

Liu Chunyu,Xie Zhiyi,Qin Long
DOI: https://doi.org/10.3969/j.issn.1008-5734.2009.03.014
2009-01-01
Abstract:A 26-year-old man was hospitalized with myalgia in his lower extremities,chest distress and palpitation.On admission,he had oliguria,dark urine,a BP of 80/50 mm Hg,and a heart rate of 120 beats/min.Laboratory test results were as follows: CK 906 U/L,CK-MB 100 U/L,ALT 310 U/L,AST 369 U/L.Urinalysis revealed the following results: WBC count 1493.2/μl,RBC count 193.1/μl,cast 65/μl,pathologic cast(+),bilirubin(++),occult blood(++),protein(++),specific gravity 1.030.Blood gas analysis revealed a pH of 6.9 and a PO2 of 64 mm Hg,which was considered to be metabolic acidosis.An IV infusion of sodium bicarbonate 5% was given.A review of his medical history showed that he had a history of chronic hepatitis B and received telbivudine 600 mg once daily for 11 months and more.Laboratory test showed his blood myoglobin level was more than 500 ng/ml.The man was diagnosed with telbivudine-associated rhabdomyolysis and treated with hemofiltration,methylprednisolone,and symptomatic therapy.Telbivudine was discontinued and changed to entecavir.The second day of hospitalisation,he had a peak CK level of 1300 U/L,a CK-MB level of 61 U/L,a ALT level of 512 U/L,and a AST level of 579 U/L.Four days later,his urine volume normalized,renal function gradually returned to within normal ranges.On day 12 of hospitalisation,his myalgia in the lower extremities markedly improved and his muscle strength recovered to grade Ⅳ;he had a CK level of 144 U/L,a CK-MB level of 15.1 U/L,a ALT level of 57 U/L,a AST level of 34 U/L,and normal electrolyte levels.
What problem does this paper attempt to address?